Poly Medicure Ltd

BSE Code : 531768
NSE Symbol : POLYMED
ISIN : INE205C01021
Industry :HEALTHCARE

Trade Now

Get Quotes

2,128.20 -30.20(-1.40%)

Open Price (₹)

2,158.40

Prev. Close (₹)

2,158.40

Volume (No’s)

58,603

Market Cap (₹)

21,870.14

Low Price (₹)

2,128.00

High Price (₹)

2,174.50

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
06-May-2025	NA	Poly Medicure Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve The Company has informed the Exchange about the Board Meeting scheduled to be held on 06th May 2025 for the purpose of approving the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March 2025 and also Final Dividend for the Financial Year ended 31st March 2025. Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 06th May, 2025, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, approved the following businesses: a. Audited Financial Results (Consolidate & Standalone) for the Fourth quarter and financial year ended on 31st March 2025. b. Recommendation of Dividend of Rs. 3.50 (Three and half Rupees) per Equity Shares (70%) of Rs. 5 each for the Financial Year 2024-25, subject to the approval of shareholders. c. Appointment of Mr. Vishal Baid, DIN: 00232727 as an Executive Director on board subject to shareholders approval in ensuing General Meeting. d. Mrs. Mukulika Baid, Non Executive Non Independent Director Step Down from the Directorship of the Company. e. Appointment of Auditor(s) (As per BSE Announcement Dated on 06/05/2025)
06-May-2025	NA	Audited Standalone & Consolidated Financial Results for the 31.03.2025
31-Mar-2025	NA	Recommendation of Dividend of Rs. 3.50 (Three and half Rupees) per Equity Shares (70%) of Rs. 5 each for the Financial Year 2024-25, subject to the approval of shareholders
03-Feb-2025	NA	POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve The Company informed the Exchange about the Board Meeting to be held on 03rd February 2025. Pursuant to the Regulation 30 of SEBI(LODR) Regulations, 2015, Company has informed about the outcome of the Board Meeting held on today i.e. 03rd February, 2025. The Company has informed about the Unaudited Financial Results ( Standalone & Consolidated ) for the Third quarter and nine months ended on 31st December, 2024 (As per BSE Announcement Dated on 03/02/2025)
23-Jan-2025	25-Jan-2025	The Company has informed about the postal ballot Notice POM 25/01/2025 (As Per BSE Bulletin Dated on 24.12.2024) The Company declared of voting results of postal ballot Pursuant to Regulation 44(3) of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 along with scrutinizers report. (As per BSE Announcement Dated on 25/01/2025)